New drug duo tested for Tough-to-Treat liver cancer
Disease control
Not yet recruiting
This study is testing whether a combination of two drugs, adebrelimab and apatinib, can help control advanced liver cancer that has continued to grow despite prior treatments. It will enroll 47 adults who have already tried at least one other systemic therapy. The main goal is to…
Phase: PHASE2 • Sponsor: Song Peng • Aim: Disease control
Last updated Apr 02, 2026 07:12 UTC